Immuneering Corp. (IMRX)
6.805
+0.42
(+6.49%)
USD |
NASDAQ |
Dec 24, 12:59
6.95
+0.14
(+2.13%)
After-Hours: 13:59
Immuneering SG&A Expense (TTM): 16.50M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 1.181B |
| Regeneron Pharmaceuticals, Inc. | 2.717B |
| Fortress Biotech, Inc. | 108.70M |
| BridgeBio Pharma, Inc. | 467.92M |
| Absci Corp. | 35.27M |